Moderna shares plummet after Covid vaccine maker lowers 2022 sales outlook

Moderna shares plummet after Covid vaccine maker lowers 2022 sales outlook


A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, September 8, 2022.

Hannah Beier | Reuters

Moderna on Thursday lowered its 2022 sales guidance for its Covid-19 vaccine after missing Wall Street expectations for the third quarter.

The Boston biotech company said it now expects to book $18 billion to $19 billion in revenue from its Covid vaccine this year, down from its previous guidance of $21 billion. Moderna said some Covid vaccine deliveries have been pushed into 2023 due to supply constraints.

Its stock was down 12% in premarket trading.

Moderna’s third quarter revenue came in at $3.36 billion, down 32% from the same period in 2021. The company booked net income of $1.04 billion for the quarter, down 68% year over year.

Here’s how the company performed compared with what Wall Street expected, based on analysts’ average estimates compiled by Refinitiv:

  • Adjusted earnings: $2.53 per share vs. $3.29 expected
  • Revenue: $3.36 billion vs $3.53 billion expected

The Covid vaccine is still Moderna’s only commercially available product. The company recently rolled out updated boosters that target the omicron BA.5 variant in the U.S.

Moderna did recently announce a partnership with Merck to develop a personalized cancer vaccine with data expected in the fourth quarter.

The company is expecting phase three efficacy data from its respiratory syncytial virus vaccine candidate this winter. It is also expecting phase three immune response data from its flu vaccine candidate in the first quarter of 2023.

This is a developing story. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Bill Gates meets Willy Wonka: How Epic’s 82-year-old billionaire CEO, Judy Faulkner, built her software factory
Health

Bill Gates meets Willy Wonka: How Epic’s 82-year-old billionaire CEO, Judy Faulkner, built her software factory

Judy Faulkner, founder and chief executive officer of Epic Systems Corp., during the Forbes Healthcare Summit in New York, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Do not go public. Do not acquire or be acquired. Software must work. These are the first three of the 10 commandments splashed across bathrooms and […]

Read More
UnitedHealth shares jump the most in 5 years after Buffett’s new stake is revealed
Health

UnitedHealth shares jump the most in 5 years after Buffett’s new stake is revealed

UnitedHealth Group Inc. signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle | Bloomberg | Getty Images Stock Chart IconStock chart icon UnitedHealth Friday Shares of UnitedHealth were down nearly 50% for 2025 through Thursday’s close before Buffett’s filing. The largest private health insurer has become the face […]

Read More
Nike co-founder Phil Knight to donate  billion to OHSU’s Knight Cancer Institute
Health

Nike co-founder Phil Knight to donate $2 billion to OHSU’s Knight Cancer Institute

Phil Knight Matthew Staver | Bloomberg | Getty Images Nike co-founder Phil Knight is donating $2 billion to the Oregon Health and Science University’s Knight Cancer Institute, the single largest donation ever to a U.S. university, college or health institution, according to the Knight Foundation. The foundation said on Thursday the gift that will be […]

Read More